OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

Smaller anterior hippocampal subfields in the early stage of psychosis
Maureen McHugo, Maxwell J. Roeske, Simon Vandekar, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Schizophrenic Psychosis and the Hippocampus: Schizophrenia Mechanisms in the Hippocampus
Carol A. Tamminga, Daniel E. Scott, Elena I. Ivleva
Oxford University Press eBooks (2025), pp. 921-932
Closed Access

Cannabidiol modulation of hippocampal glutamate in early psychosis
Aisling O’Neill, Luciano Annibale, Grace Blest‐Hopley, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 7, pp. 814-822
Open Access | Times Cited: 30

Hippocampal neuroanatomy in first episode psychosis: A putative role for glutamate and serotonin receptors
Min Tae M Park, Peter Jeon, Ali R. Khan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110297-110297
Open Access | Times Cited: 28

Synapsin 2a tetramerisation selectively controls the presynaptic nanoscale organisation of reserve synaptic vesicles
Shanley F. Longfield, Rachel S. Gormal, Matis Feller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

GDNF and miRNA-29a as biomarkers in the first episode of psychosis: uncovering associations with psychosocial factors
Marta Szwajca, Grzegorz Kazek, Natalia Śmierciak, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4

A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance
Kun Yang, Luisa Longo, Zui Narita, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1184-1191
Open Access | Times Cited: 26

Mapping Retinal Abnormalities in Psychosis: Meta-analytical Evidence for Focal Peripapillary and Macular Reductions
Jairo M. González-Díaz, Joaquim Raduà, Bernardo Sánchez‐Dalmau, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 6, pp. 1194-1205
Open Access | Times Cited: 18

Identifying common and distinct subcortical volumetric abnormalities in 3 major psychiatric disorders: a single-site analysis of 640 participants
Pei‐Chi Tu, Wan‐Chen Chang, Mu‐Hong Chen, et al.
Journal of Psychiatry and Neuroscience (2022) Vol. 47, Iss. 3, pp. E230-E238
Open Access | Times Cited: 16

Resting-state brain functional alterations and their genetic mechanisms in drug-naive first-episode psychosis
Qian Li, Xiaotao Xu, Yinfeng Qian, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10

Magnetic resonance imaging–based machine learning classification of schizophrenia spectrum disorders: a meta‐analysis
Fabio Di Camillo, David Antonio Grimaldi, Giulia Cattarinussi, et al.
Psychiatry and Clinical Neurosciences (2024)
Open Access | Times Cited: 3

The neurobiology of duration of untreated psychosis: a comprehensive review
Anthony W. Zoghbi, Jeffrey A. Lieberman, Ragy R. Girgis
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 168-190
Open Access | Times Cited: 14

Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders
Jamie J Lopes, Sean P. Carruthers, Denny Meyer, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 11, pp. 930-951
Open Access | Times Cited: 2

Volume deficits in hippocampal subfields in unaffected relatives of schizophrenia patients with high genetic loading but without any psychiatric symptoms
Sun‐Ah Choi, Minah Kim, Hyungyou Park, et al.
Schizophrenia Research (2022) Vol. 240, pp. 125-131
Closed Access | Times Cited: 11

Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
Maxwell J. Roeske, Maureen McHugo, Baxter P. Rogers, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 4, pp. 681-689
Closed Access | Times Cited: 6

Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia
Nina V. Kraguljac, Adrienne C. Lahti
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 15

Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients
Francisco Reyes-Madrigal, Elisa Guma, Pablo León-Ortíz, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 113, pp. 110473-110473
Open Access | Times Cited: 15

A Systematic Review of Cognition-Brain Morphology Relationships on the Schizophrenia-Bipolar Disorder Spectrum
James A. Karantonis, Sean P. Carruthers, Susan L. Rossell, et al.
Schizophrenia Bulletin (2021) Vol. 47, Iss. 6, pp. 1557-1600
Open Access | Times Cited: 14

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
Dominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top